Sanofi SA
PAR:SAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
PAR:SAN
|
FR |
|
D
|
DKSH Holding AG
XMUN:DS5
|
CH |
|
DKSH Holding AG
SIX:DKSH
|
CH |
|
DKSH Holding AG
OTC:DKSHF
|
CH |
|
DKSH Holding AG
F:DS5
|
CH |
Intrinsic Value
Is SAN undervalued or overvalued?
See the intrinsic value estimate for Sanofi SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sanofi Does
Sanofi is a global healthcare company that discovers, develops, makes, and sells prescription medicines and vaccines. Its main products cover areas like immunology, rare diseases, neurology, diabetes, and infectious diseases, along with preventive vaccines used by doctors, hospitals, public health systems, and pharmacies.
- Headquarters
- France FR
- Employees
- 74 846
- IPO date
- Jul 1, 2002
Sanofi has no economic moat
Patent protection keeps copies of some Sanofi medicines out, but it does not prevent rivals from developing alternative treatments. Competition against older medicines shows that these product-level protections do not provide a lasting shield across the company.
Read the full moat analysis
Earnings Waterfall
Sanofi SA
The intrinsic value for Sanofi SA (SAN) under the Base Case is hidden EUR.
Compared with the current market price of 84.53 EUR, the stock appears hidden.
